Šalis: Izraelis
kalba: anglų
Šaltinis: Ministry of Health
CEFTAZIDIME AS PENTAHYDRATE
ABIC MARKETING LTD, ISRAEL
J01DD02
POWDER FOR SOLUTION FOR INJECTION
CEFTAZIDIME AS PENTAHYDRATE 1 G/VIAL
I.V, I.M
Required
VIANEX S.A., GREECE
CEFTAZIDIME
CEFTAZIDIME
Treatment of single or multiple infections caused by susceptible microorganisms.
2015-06-30
--- --- העדוה העדוה לע לע הרמחה הרמחה ( ( עדימ עדימ ןולעב )תוחיטב ןולעב )תוחיטב ל ל אפור אפור ןכדועמ( ןכדועמ( 05.2013 05.2013 ) ) ךיראת _______ NOVEMBER 24, 2014 __ םש רישכת תילגנאב רפסמו םושירה CEFTAZIDIME TEVA POWDER FOR SOLUTION FOR INJECTION 1G: 143 79 31599 00; 2G: 143 78 31600 00 םש לעב םושירה קיבא קוויש .ד.ת ,מ"עב 8077 הינתנ _ ספוט הז דעוימ טורפל תורמחהה דבלב ! תורמחהה תושקובמה קרפ ןולעב טסקט יחכונ טסקט שדח INDICATION CONTRAINDICATIONS History of severe hypersensitivity (e.g. anaphylactic reaction) to any other type of beta-lactam antibacterial agent (penicillins, monobactams and carbapenems). POSOLOGY, DOSAGE & ADMINISTRATION SPECIAL WARNINGS AND SPECIAL PRECAUTIONS FOR USE As with all beta-lactam antibacterial agents, serious and occasionally fatal hypersensitivity reactions have been reported. In case of severe hypersensitivity reactions, treatment with ceftazidime must be discontinued immediately and adequate emergency measures must be initiated Ceftazidime has a limited spectrum of antibacterial activity. It is not suitable for use as a single agent for the treatment of some types of infections unless the pathogen is already documented and known to be susceptible or there is a very high suspicion that the most likely pathogen(s) would be suitable for treatment with ceftazidime. This particularly applies when considering the treatment of patients with bacteraemia and when treating bacterial meningitis, skin and soft tissue infections and bone and joint infections. In addition, ceftazidime is susceptible to hydrolysis by several of the extended spectrum beta lactamases (ESBLs). Therefore information on the prevalence of ESBL producing organisms should be taken into account when selecting ceftazidime for treatment. INTERACTION WITH OTHER MEDICAMENTS AND OTHER FORMS OF INTERACTION EFFECTS ON ABILITY TO DRIV Perskaitykite visą dokumentą
CEFTAZIDIME TEVA, 7. 6. 2015, RH ."רשואו קדבנ ונכותו תואירבה דרשמ י"ע עבקנ הז ןולע טמרופ" ינוי :רשואמ ןולע 2015 “This leaflet format has been determined by the Ministry of Health and the content thereof has been checked and approved.” Date of approval: June 2015 CEFTAZIDIME TEVA POWDER FOR SOLUTION FOR INJECTION FORMULATION AND STRENGTH Ceftazidime Teva 1g or 2 g, sterile powder for solution for injection. QUALITATIVE AND QUANTITATIVE COMPOSITION Injection bottle containing ceftazidime pentahydrate, equivalent to 1 g and 2 g of ceftazidime. _Other Ingredients _ Sodium carbonate (anhydrous) (E500). PHARMACEUTICAL FORM Ceftazidime Teva 1 g powder for solution for i.v./i.m. injection. Ceftazidime Teva 2 g powder for solution for i.v. injection. CLINICAL INFORMATION INDICATIONS Treatment of single or multiple infections caused by susceptible microorganisms. In meningitis it is recommended that the results of a sensitivity test are known before treatment with ceftazidime as a single agent. It may be used for infections caused by organisms resistant to other antibiotics including aminoglycosides and many cephalosporins. When appropriate, however, it may be used in combination with an aminoglycoside or most other β-lactam antibiotics for example, in the presence of severe neutropenia, or with an antibiotic active against anaerobes when the presence of _Bacteroides fragilis _ is suspected. In addition, ceftazidime is indicated in the perioperative prophylaxis of transurethral prostatectomy. _INDICATIONS INCLUDE: _ - severe infections in general - respiratory tract infections including lung infections in cystic fibrosis - ear, nose and throat infections - urinary tract infections - skin and soft tissue infections - gastrointestinal, biliary and abdominal infections - bone and joint infections - Dialysis: infections associated with haemo- and peritoneal dialysis and with continuous ambulatory peritoneal dialysis (CAPD). DOSAGE AND ADMINISTRATION Ceftazidime is to Perskaitykite visą dokumentą